Fig. 2From: Validation of biomarkers to predict response to immunotherapy in cancer: Volume II — clinical validation and regulatory considerationsThe clinical sensitivity and specificity of a biomarker assay must be demonstrated through robust receiver operative characteristics (ROC) curves. As illustrated, an ROC curve is a plot that captures true positive rate (TRP) against false positive rate (FRP) at various threshold settingsBack to article page